CAPLIN POINT LABORATORIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Caplin Point Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-2.17₹ -42.15
As on Dec 17, 2025, 4:01 PM IST
Caplin Point Laboratories Price Performance
Today's LowToday's High
₹1,883.85₹1,949.00
₹1,900.00
52 Weeks' Low52 Weeks' High
₹1,551.05₹2,636.00
₹1,900.00
Open Price
₹1,945.00
Prev. Close
₹1,942.15
Volume
1,171
Over the last 5 years, the share price of Caplin Point Laboratories has gained 30.18% CAGR. Over the past year, the corresponding return has been -22.16%.
Caplin Point Laboratories’s current P/E of 24.53x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Caplin Point Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Caplin Point Laboratories | -1.40 | -2.30 | -18.51 | -8.81 | -22.16 | 37.67 | 30.18 |
| Sun Pharmaceutical Industries | 0.32 | 1.60 | 10.60 | 8.68 | 0.14 | 21.96 | 25.69 |
| Divi's Laboratories | -0.03 | -3.56 | 3.97 | -3.76 | 7.56 | 23.41 | 10.46 |
| Torrent Pharmaceuticals | -0.96 | -1.58 | 6.01 | 15.51 | 11.14 | 33.01 | 22.19 |
| Cipla | 0.56 | -2.53 | -3.96 | -0.40 | 3.24 | 10.95 | 13.84 |
| Dr. Reddy's Laboratories | 1.59 | 2.13 | -3.05 | -3.64 | 1.84 | 13.05 | 4.60 |
| Lupin | 2.66 | 2.83 | 3.87 | 8.55 | 3.12 | 42.53 | 16.80 |
| Zydus Lifesciences | -0.63 | -1.76 | -11.31 | -4.28 | -5.33 | 30.89 | 14.08 |
| Mankind Pharma | -1.74 | -6.00 | -17.85 | -10.30 | -20.70 | 14.01 | 8.18 |
| Aurobindo Pharma | 1.51 | -3.89 | 8.47 | 7.17 | -2.01 | 39.53 | 6.40 |
| Alkem Laboratories | 0.29 | -1.90 | 2.54 | 16.65 | 4.19 | 23.22 | 13.84 |
| Abbott India | -1.25 | -6.50 | -10.56 | -12.97 | -1.18 | 9.86 | 11.43 |
| Glenmark Pharmaceuticals | -0.48 | 4.17 | -4.83 | 17.52 | 28.48 | 67.13 | 30.30 |
| Laurus Labs | -0.88 | -1.28 | 12.95 | 52.78 | 76.64 | 37.55 | 24.16 |
| Biocon | 2.02 | -8.24 | 9.09 | 9.66 | 10.19 | 13.70 | -3.45 |
| GlaxoSmithKline Pharmaceuticals | -0.44 | 3.57 | -5.68 | -20.67 | 13.92 | 24.68 | 10.23 |
| Anthem Biosciences | 3.03 | -0.26 | -23.13 | -9.12 | -9.12 | -3.14 | -1.89 |
| Ipca Laboratories | -5.00 | -4.91 | 6.04 | 2.52 | -10.70 | 17.64 | 5.16 |
| Ajanta Pharma | -1.89 | 4.06 | 1.69 | 2.29 | -9.32 | 30.31 | 18.76 |
| J B Chemicals & Pharmaceuticals | -1.77 | -2.36 | 5.02 | 3.09 | -2.66 | 20.00 | 26.95 |
Over the last one year, Caplin Point Laboratories has declined 22.16% compared to peers like Sun Pharmaceutical Industries (0.14%), Divi's Laboratories (7.56%), Torrent Pharmaceuticals (11.14%). From a 5 year perspective, Caplin Point Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (25.69%) and Divi's Laboratories (10.46%).
Caplin Point Laboratories Financials
Caplin Point Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,934.69 | 1,945.99 |
| 10 | 1,933.28 | 1,940.62 |
| 20 | 1,925.83 | 1,940.44 |
| 50 | 1,970.36 | 1,975.26 |
| 100 | 2,053.99 | 2,012.99 |
| 200 | 2,027.24 | 2,011.98 |
Caplin Point Laboratories Share Holding Pattern
In the latest quarter, Caplin Point Laboratories saw a rise in promoter holding to 70.59%, while DII stake decreased to 2.10%, FII holding rose to 6.51%, and public shareholding moved down to 20.82% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Caplin Point Laboratories Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 3,63,149 | 1.44 | 69.39 | |
| 2,90,883 | 1.01 | 55.58 | |
| 2,67,535 | 0.76 | 51.12 | |
| 1,30,837 | 2.22 | 25 | |
| 1,07,582 | 0.43 | 20.56 | |
| 10,449 | 0.86 | 2 |
* Excluding Index & Arbitrage Funds
Caplin Point Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Dec 12, 2025, 11:17 PM IST | Caplin Point Lab - Completion Of Inspection By INVIMA-Colombia At The Puducherry Injectables Facility Of The Company |
| Dec 09, 2025, 7:28 PM IST | Caplin Point Lab - Press Release On USFDA Approval |
| Dec 08, 2025, 9:07 PM IST | Caplin Point Lab - Intimation Of Press Release |
| Nov 14, 2025, 10:49 PM IST | Caplin Point Lab - Acquisition Of Land By Subsidiary |
| Nov 13, 2025, 12:20 AM IST | Caplin Point Lab - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
About Caplin Point Laboratories
Caplin Point Laboratories Ltd. is a Public Limited Listed company incorporated on 16/04/1990 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24231TN1990PLC019053 and registration number is 019053. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 752.41 Cr. and Equity Capital is Rs. 15.20 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address3rd Floor, Ashvich Towers, No.3, Developed Plots Industrial Chennai (Madras) Tamil Nadu 600096
- Contact
Management
- Mr. C C PaarthipanChairman
- Dr. Sridhar GanesanManaging Director
- Dr. R NagendranIndependent Director
- Mr. S DeenadayalanIndependent Director
- Dr. C K GariyaliIndependent Director
- Mr. R VijayaraghavanIndependent Director
FAQs on Caplin Point Laboratories Share Price
What is the share price of Caplin Point Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Caplin Point Laboratories is ₹1,900.00 as on Dec 17, 2025.
What kind of stock is Caplin Point Laboratories?
The Caplin Point Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Caplin Point Laboratories?
The market cap of Caplin Point Laboratories is ₹14,442.22 Cr as on Dec 17, 2025.
What are today's High and Low prices of Caplin Point Laboratories?
Today’s highest and lowest price of Caplin Point Laboratories are ₹1,949.00 and ₹1,883.85.
What are the 52 Week High and 52 Week Low of Caplin Point Laboratories?
The 52-week high/low is the highest and lowest price at which Caplin Point Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Caplin Point Laboratories is ₹2,636.00 and 52-week low of Caplin Point Laboratories is ₹1,551.05 as on Dec 17, 2025.
How has the Caplin Point Laboratories performed historically in terms of returns?
The Caplin Point Laboratories has shown returns of -2.17% over the past day, -2.3% for the past month, -18.51% over 3 months, -22.16% over 1 year, 37.67% across 3 years, and 30.18% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Caplin Point Laboratories?
P/E ratio of and PB ratio of Caplin Point Laboratories are 24.53 and 5.68 on Dec 17, 2025. While the company gives a dividend yield of 0.32 per annum.
Caplin Point Laboratories News
✕
Market Pulse